Google Translate Limitations Disclaimer

The electronic translation service on the brainXchange website is hosted by Google Translate, an external translation service. The brainXchange does not guarantee or warrant the reliability, accuracy or completeness of any translated information. The basic translation goal is to capture the general information of the original English website content. If any questions arise related to the accuracy of the information contained in the translated website, please refer to the English version of the website.

Home > Events > Archived Webinars & Events > 2022 > Distinguishing behavioural variant frontotemporal dementia (bvFTD) from psychiatric disorders

Distinguishing behavioural variant frontotemporal dementia (bvFTD) from psychiatric disorders

Event Date: Mar 31, 2022

Related Resources l Recording

This presentation will review clinical features of behavioral variant frontotemporal (bvFTD) dementia. We will focus on the complexities of differentiating primary psychiatric disorders from frontotemporal dementia (FTD) in the clinical context. We will discuss recent developments in diagnostic approaches and tests for FTD, and how those can be integrated in clinical practice.

This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA).

Presenter(s):

Simon Ducharme, MD, MSc, FRCPC, Department of Psychiatry, McGill University

Dr. Ducharme is a Neuropsychiatrist and a clinician-scientist at the Douglas Mental Health University Institute and The Neuro (MNI). He is specialized in frontotemporal dementia, and the interface between psychiatric disorders and dementia. His research program uses advanced neuroimaging techniques to develop diagnostic biomarkers for frontotemporal dementia. Dr. Ducharme holds a Junior 2 clinician-scientist award from the FRQS and his research projects are funded by the CIHR, Weston Brain Institute, JPND, Medteq and Prompt-AI. He is in charge of several innovative clinical trials on dementia at The Neuro and he is the author of over 90 scientific articles and 7 book chapters. Dr. Ducharme is the director of the McGill Division of Geriatric Psychiatry & Neuropsychiatry and the director of the American Neuropsychiatric Association committee on research.